ATEMPT 2.0: Adjuvant T-DM1 vs TH
for Breast Cancer
Sites in Scarborough, Brewer +44 more locations
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: 18+
Code: NCT04893109·Phase 2·Recruiting·Listed May 2021
Oncology Clinical Trials in Scarborough, ME
As of August 2026, 48 paid clinical trials are recruiting for Oncology in Scarborough, Maine. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
48 clinical trials for Oncology
·Clear filters· Email me when a new oncology trial opens in Scarborough, ME.
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for Head and Neck Squamous Cell Carcinoma
Sites in Scarborough, Portland +167 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06992427·Phase 3·Recruiting·Listed May 2025
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for Breast Carcinoma
Sites in Scarborough, South Portland +462 more locations
Sponsor: Wake Forest University Health Sciences
Sex: All·Age: 18+
Code: NCT06418204·Recruiting·Listed May 2024
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
for Chronic Lymphocytic Leukemia
Sites in Scarborough +3 more locations
Sponsor: Inhye Ahn
Sex: All·Age: 18+
Code: NCT06333262·Phase 2·Recruiting·Listed Mar 2024
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for Hodgkin Lymphoma in Remission
Sites in Scarborough +55 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: All ages
Code: NCT01790152·Recruiting·Listed Feb 2013
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for Rhabdomyosarcoma
Sites in Scarborough, Portland +83 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 50
Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
for Endometrial Cancer
Sites in Scarborough +66 more locations
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
Drug: Rilvegostomig
Sites in Scarborough +64 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024
Conditions in Oncology (Scarborough, ME)
Acute myeloid leukemia (AML)· 9Non-small cell lung cancer (NSCLC)· 8Solid tumor· 8Breast cancer· 7Ovarian cancer· 7Endometrial cancer· 4Non-Hodgkin lymphoma· 4Melanoma· 4Chronic lymphocytic leukemia (CLL)· 3Leukemia (other)· 3Myelodysplastic syndromes (MDS)· 3Hematologic malignancy· 3Metastatic breast cancer· 2HER2-positive breast cancer· 2Acute lymphoblastic leukemia· 2Myeloproliferative neoplasm· 2Small lymphocytic lymphoma· 2Osteosarcoma· 2Neuroblastoma· 2Cancer (any)· 2Triple-negative breast cancer· 1Colorectal cancer· 1Gastroesophageal junction cancer· 1Biliary tract cancer· 1Prostate cancer· 1Bladder cancer· 1Kidney cancer· 1Cervical cancer· 1Fallopian tube cancer· 1Glioblastoma· 1Multiple myeloma· 1Myelofibrosis· 1Follicular lymphoma· 1Mantle cell lymphoma· 1Marginal zone lymphoma· 1Head and neck cancer· 1Sarcoma· 1Rhabdomyosarcoma· 1Neuroendocrine tumors· 1